Roche (RHHBY) Breast Cancer Drug Gets FDA Priority Review 2/8/2012 8:12:29 AMRoche Holding AG Wednesday said the U.S. Food and Drug Administration has accepted the company’s Biologics License Application for pertuzumab and granted Priority Review
Roche Breast Cancer Drug Gets FDA Priority Review
Sursa:
Roche Breast Cancer Drug Gets FDA Priority Review